Skip to main content
 

HIV'S PERSISTENCE

Progress, inspiration, and hope: these three words aptly describe this issue. We interview six prominent women scientists involved in everything from vaccine research to implementing global HIV treatment programs and ask about what drives them to continue working in HIV/AIDS more than 30 years into this pandemic. Their answers are inspiring and in some cases surprising. Another article follows esteemed researcher Steve Deeks from the University of California in San Francisco as he navigates the recently held Keystone Symposium on HIV Persistence: Implications for a Cure. His broad history in and knowledge of the HIV treatment and cure fields, as well as his droll sense of humor, are on full display. We also report in detail on a trio of recently published research papers showcasing progress in developing and testing vaccine immunogens designed to induce broadly neutralizing antibodies. Read more...

LATEST BLOG POSTS

If you build it, they will come

READ MORE
Global HIV Treatment Guidelines May Be Revised Based on Study

READ MORE
Antibodies Re-Energize Vaccine Investigations

READ MORE
Answering the Call: Battling Ebola with Experience

READ MORE

Recent Features

Living Positive in Malaysia

Q&A with Andrew Tan, founder and president of myPlus, a network of HIV-positive people in Malaysia. Tan came out in public as an HIV-positive gay man in his speech opening night of IAS 2013.

READ MORE

Clinical Trials Database

image description Explore

An interactive search of trials and results

READ MORE

Upcoming Meetings

8th IAS Conference on HIV Pathogenesis, Treatment & Prevention July 19 - 22, 2015 Vancouver, Canada
7th International Workshop on HIV Persistence, Reservoirs and Cure December 08 - 11, 2015 Miami, Florida
view all

Not a Scientist?

cover art url

VAX is the bulletin on AIDS vaccine research for you.

Rainbow Nation Redux

A full spectrum of interests in HIV prevention research, brought together for the first time.

READ MORE

DOWNLOAD PDF